Troubled drugstore chain CVS Health (CVS) reported Fiscal fourth-quarter results that beat on the top and bottom lines, ...
In a report released today, Andrew Mok CFA from Barclays maintained a Hold rating on Humana (HUM – Research Report), with a price target of $255.00. The company’s shares closed last Friday at ...
Despite posting a net loss of $693 million in the fourth quarter of 2024, Humana’s total revenue for the year increased 10.7% ...
Humana Inc. closed 37.78% short of its 52-week high of $406.46, which the company achieved on July 18th.
Humana's financial results for Q4 and for full-year 2024 show a 10% revenue increase, but that's about the only bright spot ...
I had my drs (who know it’s me) send my prescriptions to another pharmacy (where no one knows me) before the end of the month and placed the refilled narcotics on Humana prescription card then ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results